Clinical trial No longer in our active list Interventional Ages 18 to 70

Comparing two surgical methods for treating cervical ossification of the posterior longitudinal ligament

Official title: An Open-label Randomized Multi-centre Study to Evaluate Anterior Controllable Antedisplacement and Fusion Versus Posterior Laminoplasty in Patients With Cervical Ossification of the Posterior Longitudinal Ligament

Run by Shanghai Changzheng Hospital · NCT04968028 · Data updated 2026-05-14

This study is no longer in our active list. It may have stopped recruiting or finished. The details below are as of 2026-05-14 and are kept for reference. Check ClinicalTrials.gov for its current status, or see similar studies below.

This study is testing whether a new surgical method called ACAF is safer and more effective than a traditional surgery called Laminoplasty for adults with severe neck problems caused by ossification of the posterior longitudinal ligament.

Quick facts

Study typeInterventional
Ages18 Years to 70 Years
SexAll
Enrollment164 (estimated)
SponsorShanghai Changzheng Hospital
Academic / other
Locations12 sites (Shenzhen, Guangdong and 11 other locations)
Trial IDNCT04968028 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates for this study are adults aged 18-70 diagnosed with severe ossification of the posterior longitudinal ligament and experiencing symptoms of spinal cord compression.

Probably not a fit

Patients with congenital malformations, other spinal diseases, or inflammatory conditions affecting the cervical spine may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This multicenter, prospective, randomized controlled trial aims to evaluate the safety and efficacy of Anterior Controllable Antedisplacement and Fusion (ACAF) compared to Laminoplasty in patients with severe ossification of the posterior longitudinal ligament. A total of 164 adult participants aged 18-70 will be randomly assigned to either the ACAF or Laminoplasty group in a 1:1 ratio. The study will follow participants for two years to assess outcomes related to efficacy, safety, and imaging results.

Why it matters

Potential benefit: If successful, this study could provide a more effective surgical option for patients suffering from severe cervical ossification, potentially improving their quality of life.

How similar studies have gone: While there have been studies on surgical interventions for cervical ossification, this specific comparison of ACAF and Laminoplasty is novel and has not been extensively tested.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

1. The patient's age is 18-70 years old, regardless of gender;
2. The patient was diagnosed as severe ossification of the posterior longitudinal ligament (X-ray or CT showed ossification of the posterior longitudinal ligament); The imaging findings showed occupied ratio ≥ 60% or involved three or more segments;
3. Symptoms of spinal cord and nerve root compression, or accompanied by spinal cord compression symptoms such as dysfunction of urination and defecation, conservative treatment was ineffective or aggravated gradually;
4. The participant (or his legal guardian) can sign the informed consent.

Exclusion Criteria:

1. Congenital malformations (including but not limited to occipitocervical malformations, congenital cervical fusion, cervical related neurovascular malformations), ossification of cervical ligamentum flavum, cervical trauma, cervical cancer, cervical tuberculosis and other inflammatory diseases;
2. Patients with other spinal diseases such as thoracolumbar vertebrae that affect clinical symptoms; Patients with motor neuron diseases such as amyotrophic lateral sclerosis and other nervous system diseases;
3. The symptoms were aggravated due to recent trauma;
4. Patients who participated in other clinical trials in recent 3 months;
5. The participant (or his legal guardian) with mental illness and cognitive impairment can not give full informed consent;
6. Those who are in poor health and can not tolerate surgery; The patients were not suitable for surgical treatment after preoperative examination.

Where it's running

  • Peking University Shenzhen Hospital
    Shenzhen, Guangdong, China
    Recruiting
  • Xuanwu Hospital Capital Medical University
    Pekin, Pekin, China
    Recruiting
  • Affiliated Hospital of Jining Medical University
    Jining, Shandong, China
    Recruiting
  • The Affiliated Hospital of Qingdao University
    Qingdao, Shandong, China
    Recruiting
  • Shanghai Changzheng Hospital
    Shanghai, Shanghai, China
    Recruiting
  • The First Affiliated Hospital of Shanghai Jiao Tong University
    Shanghai, Shanghai, China
    Recruiting
Show 6 more locations
  • Shanghai Tongji Hospital, School of Medicine, Tongji University
    Shanghai, Shanghai, China
    Recruiting
  • Shanxi Bethune Hospital
    Taiyuan, Shanxi, China
    Recruiting
  • The Second Affiliated Hospital, Air Force Medical University
    Xi'an, Shanxi, China
    Recruiting
  • The 2nd Affiliated Hospital of Harbin Medical University
    Harbin, Heilongjaing, China
    Not yet recruiting
  • Shanghai Sixth People's Hospital
    Shanghai, Shanghai, China
    Not yet recruiting
  • Shanghai Changhai Hospital
    Shanghai, Shanghai, China
    Not yet recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.